Trodelvy® Significantly Improved Quality of Life Over Standard of Care in 2L+ Metastatic Triple-Negative Breast Cancer in Phase 3 ASCENT Study Biotech Investing
Five-Year Data from CheckMate -214 Show Opdivo Plus Yervoy Demonstrates Longest Median Overall Survival Currently Reported in Phase 3 Trial of Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma Biotech Investing
LUMAKRAS Combined With Vectibix® Showed Encouraging Efficacy And Safety In Patients With KRAS G12C-Mutated Colorectal Cancer Biotech Investing
SHAREHOLDER ALERT: WeissLaw LLP Reminds DSPG, ADTN, TRIL, and STMP Shareholders About Its Ongoing Investigations Biotech Investing
Amgen And The Lundquist Institute Announce That Diadem Therapeuctics Will Receive The First Amgen Golden Ticket To BioLabs LA Biotech Investing
Amgen To Present At The 2021 Bank of America Merrill Lynch Global Healthcare Conference Biotech Investing
Amgen To Showcase New Data From Inflammation Portfolio At EADV Virtual Congress 2021 Biotech Investing
Wellteq Digital Health Inc. to Present at the Virtual Gravitas Health Reimagined Investor Day Biotech Investing
Gilead to Present New Data at ESMO Congress 2021 Reinforcing the Practice-changing Potential of Trodelvy Biotech Investing
